Cargando…
Design, synthesis, and biological evaluation of novel dipeptide-type SARS-CoV 3CL protease inhibitors: Structure–activity relationship study
This work describes the design, synthesis, and evaluation of low-molecular weight peptidic SARS-CoV 3CL protease inhibitors. The inhibitors were designed based on the potent tripeptidic Z-Val-Leu-Ala(pyrrolidone-3-yl)-2-benzothiazole (8; K(i) = 4.1 nM), in which the P3 valine unit was substituted wi...
Autores principales: | Thanigaimalai, Pillaiyar, Konno, Sho, Yamamoto, Takehito, Koiwai, Yuji, Taguchi, Akihiro, Takayama, Kentaro, Yakushiji, Fumika, Akaji, Kenichi, Kiso, Yoshiaki, Kawasaki, Yuko, Chen, Shen-En, Naser-Tavakolian, Aurash, Schön, Arne, Freire, Ernesto, Hayashi, Yoshio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115367/ https://www.ncbi.nlm.nih.gov/pubmed/23747811 http://dx.doi.org/10.1016/j.ejmech.2013.05.005 |
Ejemplares similares
-
Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: Design, synthesis, biological evaluation, and docking studies
por: Thanigaimalai, Pillaiyar, et al.
Publicado: (2013) -
Design and synthesis of new tripeptide-type SARS-CoV 3CL protease inhibitors containing an electrophilic arylketone moiety
por: Konno, Sho, et al.
Publicado: (2013) -
An Overview of
Severe Acute Respiratory Syndrome–Coronavirus
(SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule
Chemotherapy
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2016) -
New developments for the design, synthesis and biological evaluation of potent SARS-CoV 3CL(pro) inhibitors
por: Regnier, Thomas, et al.
Publicado: (2009) -
Skin whitening agents: medicinal chemistry perspective of tyrosinase inhibitors
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2017)